[{"data":1,"prerenderedAt":46},["ShallowReactive",2],{"q-nurse-106-2-medical-surgical-078":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":23},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":22},"nurse-106-2-內外科護理學-078","nurse-106-2-medical-surgical-078",106,2,78,"有關末期腎疾病（ESRD）病人，因腎性貧血接受紅血球生成素（EPO）治療之準則，下列何者錯誤？",{"A":14,"B":15,"C":16,"D":17},"血球比容至少要達到 35%","血清鐵蛋白應大於 200 ng\u002FmL","運鐵蛋白飽和度應大於 20%","無惡性高血壓","A",null,[],"本題考點在末期腎病腎性貧血使用紅血球生成素（EPO）的治療準則。EPO 治療目標並非把血比容（Hct）拉到正常，而是控制在適度範圍以避免高血壓、血栓等風險，一般 Hct 目標約 33～36%、Hb 約 10～12 g\u002FdL，過高反增心血管事件；A 稱「至少要達 35%」把下限訂太高、方向錯誤，故選 A。B 對，鐵儲備充足是 EPO 有效前提，血清鐵蛋白應大於 200 ng\u002FmL；C 對，運鐵蛋白飽和度應大於 20%，確保有鐵可供造血；D 對，惡性高血壓未控制時不宜用 EPO，以免血壓進一步惡化。",1,[24,27,30,34,38,42],{"webId":25,"stem":26,"number":22,"year":9,"session":22},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",{"webId":28,"stem":29,"number":10,"year":9,"session":22},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",{"webId":31,"stem":32,"number":33,"year":9,"session":22},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",3,{"webId":35,"stem":36,"number":37,"year":9,"session":22},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":39,"stem":40,"number":41,"year":9,"session":22},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":43,"stem":44,"number":45,"year":9,"session":22},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840737532]